Company China Health Industries Holdings, Inc. Other OTC
Equities
CHHE
US1693981045
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Humankind
100.0
%
| 0 | 0.0 % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +41,689.89% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Xin Sun
CEO | Chief Executive Officer | 58 | - |
Melody Zhang
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Xin Sun
CEO | Chief Executive Officer | 58 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 65,539,737 | 45,032,549 ( 68.71 %) | 0 | 68.71 % |
Company contact information
China Health Industries Holdings, Inc.
3199-1 Longxiang Road Songbei District
150028, Harbin
+
http://www.chinahealthindustries.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+31.37% | 59TCr | |
-2.76% | 36TCr | |
+20.52% | 33TCr | |
+5.52% | 29TCr | |
+14.83% | 24TCr | |
+9.93% | 21TCr | |
-6.95% | 20TCr | |
+11.24% | 17TCr | |
+0.09% | 16TCr |